Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24882 | 249 | 39.5 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GICERIN | Author keyword | 41 | 100% | 6% | 15 |
2 | CD146 | Author keyword | 27 | 46% | 17% | 43 |
3 | NEURITE OUTGROWTH FACTOR | Author keyword | 14 | 100% | 3% | 7 |
4 | MCAM | Author keyword | 7 | 41% | 6% | 14 |
5 | MUC18 | Author keyword | 7 | 53% | 4% | 9 |
6 | MELANOMA CELL ADHESION MOLECULE | Author keyword | 6 | 71% | 2% | 5 |
7 | SOLUBLE CD146 | Author keyword | 6 | 100% | 2% | 4 |
8 | CAS UNIV TOKYO JOINT STRUCT VIROL IMMUNOL | Address | 5 | 50% | 3% | 7 |
9 | CD146 MCAM | Author keyword | 3 | 60% | 1% | 3 |
10 | MD ANDERSON CANCER CELL BIOL | Address | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GICERIN | 41 | 100% | 6% | 15 | Search GICERIN | Search GICERIN |
2 | CD146 | 27 | 46% | 17% | 43 | Search CD146 | Search CD146 |
3 | NEURITE OUTGROWTH FACTOR | 14 | 100% | 3% | 7 | Search NEURITE+OUTGROWTH+FACTOR | Search NEURITE+OUTGROWTH+FACTOR |
4 | MCAM | 7 | 41% | 6% | 14 | Search MCAM | Search MCAM |
5 | MUC18 | 7 | 53% | 4% | 9 | Search MUC18 | Search MUC18 |
6 | MELANOMA CELL ADHESION MOLECULE | 6 | 71% | 2% | 5 | Search MELANOMA+CELL+ADHESION+MOLECULE | Search MELANOMA+CELL+ADHESION+MOLECULE |
7 | SOLUBLE CD146 | 6 | 100% | 2% | 4 | Search SOLUBLE+CD146 | Search SOLUBLE+CD146 |
8 | CD146 MCAM | 3 | 60% | 1% | 3 | Search CD146+MCAM | Search CD146+MCAM |
9 | MEL CAM | 2 | 29% | 2% | 5 | Search MEL+CAM | Search MEL+CAM |
10 | ADHESION MOLECULE CD146 | 1 | 100% | 1% | 2 | Search ADHESION+MOLECULE+CD146 | Search ADHESION+MOLECULE+CD146 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEURITE OUTGROWTH FACTOR | 81 | 96% | 10% | 25 |
2 | MUC18 | 58 | 83% | 13% | 33 |
3 | ANTI CD146 MONOCLONAL ANTIBODY | 35 | 86% | 7% | 18 |
4 | MUC18 CDNA GENE | 15 | 88% | 3% | 7 |
5 | CD146 | 9 | 45% | 6% | 15 |
6 | MEL CAM | 9 | 59% | 4% | 10 |
7 | SOLUBLE CD146 | 6 | 100% | 2% | 4 |
8 | GICERIN | 5 | 63% | 2% | 5 |
9 | S ENDO 1 | 4 | 75% | 1% | 3 |
10 | MCAM MUC18 | 4 | 56% | 2% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CD146, a multi-functional molecule beyond adhesion | 2013 | 32 | 150 | 80% |
Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146 | 2009 | 53 | 98 | 57% |
Cell adhesion molecules in the development and progression of malignant melanoma | 1999 | 184 | 100 | 16% |
The multifaceted role of CD146/MCAM in the promotion of melanoma progression | 2015 | 0 | 69 | 59% |
Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8 | 2006 | 41 | 74 | 27% |
Endothelial-binding, proinflammatory T cells identified by MCAM (CD146) expression: Characterization and role in human autoimmune diseases | 2015 | 0 | 46 | 52% |
The role of gicerin, a novel cell adhesion molecule, in development, regeneration and neoplasia | 2001 | 9 | 28 | 57% |
The role of CD146 (Mel-CAM) in biology and pathology | 1999 | 3 | 31 | 71% |
Transcriptional control of melanoma metastasis: The importance of the tumor microenvironment | 2011 | 34 | 91 | 12% |
Tumor immunotherapy in melanoma - Strategies for overcoming mechanisms of resistance and escape | 2008 | 27 | 42 | 14% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CAS UNIV TOKYO JOINT STRUCT VIROL IMMUNOL | 5 | 50% | 2.8% | 7 |
2 | MD ANDERSON CANCER CELL BIOL | 2 | 67% | 0.8% | 2 |
3 | PROT PEPTIDE PHARMACEUT | 2 | 14% | 5.2% | 13 |
4 | CHINESE SCI UNIV TOKYO JOINT STRUCT VIRO | 2 | 36% | 1.6% | 4 |
5 | MED PHARMACOL 1 | 2 | 43% | 1.2% | 3 |
6 | IMMUNOL PR BONGRAND | 1 | 100% | 0.8% | 2 |
7 | INSERM EMI 0019 | 1 | 100% | 0.8% | 2 |
8 | JOINT STRUCT VIROL IMMUNOL | 1 | 33% | 1.2% | 3 |
9 | EMI 0019 | 1 | 40% | 0.8% | 2 |
10 | EQUIPE RECH CLIN | 1 | 40% | 0.8% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000162349 | ALCAM//CD166//CD6 |
2 | 0.0000122699 | BRANCHIO OCULO FACIAL SYNDROME//AP 2//AP 2 ALPHA |
3 | 0.0000088077 | ACUTE REJECTION REACTION//TUMOR ANGIOGENESIS//E S 8 |
4 | 0.0000080487 | MIA//CIRCULATING MELANOMA CELLS//MELANOMA INHIBITORY ACTIVITY |
5 | 0.0000070049 | OBSTET FETAL MATERNAL MED//EXTRAVILLOUS TROPHOBLAST//TROPHOBLAST INVASION |
6 | 0.0000058513 | PECAM 1//JAM A//JUNCTIONAL ADHESION MOLECULE A |
7 | 0.0000055705 | POLYVALENT ANTIGEN//AUTOLOGOUS ANTIBODY//B700 |
8 | 0.0000052649 | RARRES3//TIG3//H REV107 |
9 | 0.0000049501 | ALKALINE TIDE//HUMAN OSCC//IN VIVO ENVIRONMENT |
10 | 0.0000047527 | L1 CAM//X LINKED HYDROCEPHALUS//MASA SYNDROME |